We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fluvoxamine lowers hospitalization risk in patients with COVID‐19.
- Abstract
The article presents the discussion on identifying effective therapies against COVID-19 including an examination of potential repurposing of existing medications. Topics include evaluation of fluvoxamine's effect on the progression of COVID-19 compared with placebo; and fluvoxamine, an inexpensive existing drug reducing the need for advanced disease care in the high-risk population.
- Subjects
DISEASE progression; ANTIDEPRESSANTS; COVID-19; FLUVOXAMINE; ANTI-inflammatory agents; ANTIVIRAL agents; TREATMENT effectiveness; HOSPITAL care; MEDICAL research
- Publication
Brown University Psychopharmacology Update, 2022, Vol 33, Issue 2, p6
- ISSN
1068-5308
- Publication type
Article
- DOI
10.1002/pu.30829